← Browse by Condition
Medical Condition

liver transplantation

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for liver transplantation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — liver transplantation Clinical Trials

How many clinical trials are currently recruiting for liver transplantation?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for liver transplantation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for liver transplantation?
liver transplantation research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a liver transplantation clinical trial?
Eligibility criteria for liver transplantation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Seoul National University Hospital 1 trial
Hospices Civils de Lyon 1 trial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1 trial
RenJi Hospital 1 trial
Ankara Etlik City Hospital 1 trial

Recruiting Clinical Trials

NCT04622540
Recruiting
EBD RCT Trial in Living Donor Liver Transplantation
Enrollment
124 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT06899867
Recruiting
Comparing Montiroing Cardiac Index by Transpulmonary Thermodilution and Transesophageal Echocardiography During Liver Transplantation
Enrollment
30 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT05475613 Phase 2
Recruiting
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation
Enrollment
59 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
View Trial →
NCT05326399
Recruiting
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
Enrollment
369 pts
Location
China
Sponsor
RenJi Hospital
View Trial →
NCT07123740
Recruiting
Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Ankara Etlik City Hospital
View Trial →

Related Conditions

liver transplant complications (1) bile stricture (1) bile leakage from biliary anastomosis (1) hepatocellular carcinoma (1) renal insufficiency chronic (1) pain management (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology